Stay updated on Nusinersen Safety in SMA Clinical Trial
Sign up to get notified when there's something new on the Nusinersen Safety in SMA Clinical Trial page.

Latest updates to the Nusinersen Safety in SMA Clinical Trial page
- Check3 days agoChange DetectedNo substantial changes were detected in the study details, design, eligibility criteria, or outcomes; the update appears to be minor formatting adjustments and a revised timestamp.SummaryDifference0.4%

- Check10 days agoNo Change Detected
- Check32 days agoChange Detected- Added new topic: Spinal muscular atrophy and updated to revision v3.2.0. - Removed specific term: Proximal spinal muscular atrophy and previous revision v3.1.0.SummaryDifference2%

- Check39 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update aSummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding 'München, Germany, 80337' and 'nusinersen' while removing references to 'Amyotrophic Lateral Sclerosis' and other related terms.SummaryDifference1%

Stay in the know with updates to Nusinersen Safety in SMA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nusinersen Safety in SMA Clinical Trial page.